| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Jun 3, 2025 | HAEMONETICS CORP | CFO | Sell | 97.5 | +6,357 | 28.98% | ✗ | $406.8K |
| May 15, 2025 | May 19, 2025 | HAEMONETICS CORP | CFO | Sell | 22.5 | -1,868 | -11.19% | ✗ | $130.8K |
| May 2, 2025 | May 5, 2025 | HAEMONETICS CORP | CFO | Sell | 26.3 | -654 | -3.77% | ✗ | $41.8K |
| May 15, 2024 | May 17, 2024 | HAEMONETICS CORP | CFO | Sell | 22.5 | -763 | -5.58% | ✗ | $73K |
| May 2, 2024 | May 6, 2024 | HAEMONETICS CORP | CFO | Sell | 26.3 | -432 | -3.06% | ✗ | $40.3K |
| May 15, 2023 | May 17, 2023 | HAEMONETICS CORP | CFO | Sell | 91.3 | +3,856 | 37.63% | ✗ | $31.1K |
| May 2, 2023 | May 4, 2023 | HAEMONETICS CORP | CFO | Sell | 26.3 | -430 | -4.03% | ✗ | $35.1K |
| Aug 10, 2021 | Aug 12, 2021 | TherapeuticsMD, Inc. | CFO | Sell | 22.5 | -93,337 | -42.98% | ✗ | $81.2K |